The pharmaceutical industry is adopting new technologies to modify how they monitor, control, and optimize its supply chains. Pharmaceutical companies are leveraging AI and ML technologies that are increasingly applied in pharma analytics, enabling the analysis of identification of patterns and trends, large and complex datasets, prediction of outcomes, and optimization of drug development processes. The integration of cutting-edge technologies has the potential to automate and expedite numerous drug discovery processes, reducing the production costs of pharmaceuticals.
The commercial pharmaceutical analytics market is anticipated to grow from $16.408 Bn in 2023 to $65.5414 Bn by 2032 at a CAGR of 18.90 percent. Using pharma analytics to streamline business processes in the pharma industry drives the demand for commercial pharmaceutical analytics. Technological advancements and increased investor interest in healthcare analytical tools will drive the growth of the pharma analytics market. The innovative technologies and analytical tools ensure improved quality and compliance by minimizing manual errors and variability and facilitating faster advancements in reliability and validity.
This edition of Pharma Tech Outlook brings recent trends and developments in pharma analytics and the latest technologies, bringing more efficiency, proactive decision-making, and improving efficiency in the pharma sector.
It features a thought leadership article from James Riddle, MCSE, CIP, CPIA, CRQM, Vice President, Research Services & Strategic Consulting at Advarra, discussing how immunotherapy and gene editing may cure previously incurable conditions. It also features a thought leadership article from Rhona Macdonald, Head of Clinical Research at Douglas Pharmaceuticals, who sheds light on the need to focus intensely on research and development in mental health research and the importance of developing new and innovative products.
In this edition, we also bring you the story of some top pharma analytics solution providers delivering innovative technologies and solutions in the pharma sector. One of them is Kalypso, a Rockwell Automation business that helps clients fundamentally change the way they discover, create, make, and sell products by powering innovation and autonomous operations with a digital value chain.
This edition featuring pharma analytics solution providers 2023 facilitates the growing focus on patient-centric analytics, which involves understanding patient preferences and outcomes. We hope you find the right partner to meet organizational needs.
